These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 8843627)

  • 1. PspA, a protection-eliciting pneumococcal protein: immunogenicity of isolated native PspA in mice.
    Briles DE; King JD; Gray MA; McDaniel LS; Swiatlo E; Benton KA
    Vaccine; 1996 Jun; 14(9):858-67. PubMed ID: 8843627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regions of PspA/EF3296 best able to elicit protection against Streptococcus pneumoniae in a murine infection model.
    Roche H; Håkansson A; Hollingshead SK; Briles DE
    Infect Immun; 2003 Mar; 71(3):1033-41. PubMed ID: 12595413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A 43-kilodalton pneumococcal surface protein, PspA: isolation, protective abilities, and structural analysis of the amino-terminal sequence.
    Talkington DF; Crimmins DL; Voellinger DC; Yother J; Briles DE
    Infect Immun; 1991 Apr; 59(4):1285-9. PubMed ID: 2004810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PspA, a surface protein of Streptococcus pneumoniae, is capable of eliciting protection against pneumococci of more than one capsular type.
    McDaniel LS; Sheffield JS; Delucchi P; Briles DE
    Infect Immun; 1991 Jan; 59(1):222-8. PubMed ID: 1987036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protection elicited by nasal immunization with pneumococcal surface protein A (PspA) adjuvanted with bacterium-like particles against Streptococcus pneumoniae infection in mice.
    Li B; Chen X; Yu J; Zhang Y; Mo Z; Gu T; Kong W; Wu Y
    Microb Pathog; 2018 Oct; 123():115-119. PubMed ID: 29959043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Localization of protection-eliciting epitopes on PspA of Streptococcus pneumoniae between amino acid residues 192 and 260.
    McDaniel LS; Ralph BA; McDaniel DO; Briles DE
    Microb Pathog; 1994 Nov; 17(5):323-37. PubMed ID: 7723659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multivalent Pneumococcal Protein Vaccines Comprising Pneumolysoid with Epitopes/Fragments of CbpA and/or PspA Elicit Strong and Broad Protection.
    Chen A; Mann B; Gao G; Heath R; King J; Maissoneuve J; Alderson M; Tate A; Hollingshead SK; Tweten RK; Briles DE; Tuomanen EI; Paton JC
    Clin Vaccine Immunol; 2015 Oct; 22(10):1079-89. PubMed ID: 26245351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective Immune Responses Elicited by Fusion Protein Containing PsaA and PspA Fragments.
    Lu J; Sun T; Wang D; Dong Y; Xu M; Hou H; Kong FT; Liang C; Gu T; Chen P; Sun S; Lv X; Jiang C; Kong W; Wu Y
    Immunol Invest; 2015; 44(5):482-96. PubMed ID: 26107747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The potential to use PspA and other pneumococcal proteins to elicit protection against pneumococcal infection.
    Briles DE; Hollingshead S; Brooks-Walter A; Nabors GS; Ferguson L; Schilling M; Gravenstein S; Braun P; King J; Swift A
    Vaccine; 2000 Feb; 18(16):1707-11. PubMed ID: 10689153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of a vaccine formulation against Streptococcus pneumoniae based on choline-binding proteins.
    Miyaji EN; Vadesilho CF; Oliveira ML; Zelanis A; Briles DE; Ho PL
    Clin Vaccine Immunol; 2015 Feb; 22(2):213-20. PubMed ID: 25520146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intranasal immunization with recombinant PspA fused with a flagellin enhances cross-protective immunity against Streptococcus pneumoniae infection in mice.
    Nguyen CT; Kim SY; Kim MS; Lee SE; Rhee JH
    Vaccine; 2011 Aug; 29(34):5731-9. PubMed ID: 21696869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Truncated Streptococcus pneumoniae PspA molecules elicit cross-protective immunity against pneumococcal challenge in mice.
    Tart RC; McDaniel LS; Ralph BA; Briles DE
    J Infect Dis; 1996 Feb; 173(2):380-6. PubMed ID: 8568299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic and mucosal protective immunity to pneumococcal surface protein A.
    Briles DE; Tart RC; Wu HY; Ralph BA; Russell MW; McDaniel LS
    Ann N Y Acad Sci; 1996 Oct; 797():118-26. PubMed ID: 8993356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pneumococcal diversity: considerations for new vaccine strategies with emphasis on pneumococcal surface protein A (PspA).
    Briles DE; Tart RC; Swiatlo E; Dillard JP; Smith P; Benton KA; Ralph BA; Brooks-Walter A; Crain MJ; Hollingshead SK; McDaniel LS
    Clin Microbiol Rev; 1998 Oct; 11(4):645-57. PubMed ID: 9767061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The proline-rich region of pneumococcal surface proteins A and C contains surface-accessible epitopes common to all pneumococci and elicits antibody-mediated protection against sepsis.
    Daniels CC; Coan P; King J; Hale J; Benton KA; Briles DE; Hollingshead SK
    Infect Immun; 2010 May; 78(5):2163-72. PubMed ID: 20194601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of pneumococcal surface protein A in the virulence of Streptococcus pneumoniae.
    Briles DE; Yother J; McDaniel LS
    Rev Infect Dis; 1988; 10 Suppl 2():S372-4. PubMed ID: 3187321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective efficacy of PspA (pneumococcal surface protein A)-based DNA vaccines: contribution of both humoral and cellular immune responses.
    Miyaji EN; Dias WO; Tanizaki MM; Leite LC
    FEMS Immunol Med Microbiol; 2003 Jun; 37(1):53-7. PubMed ID: 12770760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pneumococcal surface protein A (PspA) is serologically highly variable and is expressed by all clinically important capsular serotypes of Streptococcus pneumoniae.
    Crain MJ; Waltman WD; Turner JS; Yother J; Talkington DF; McDaniel LS; Gray BM; Briles DE
    Infect Immun; 1990 Oct; 58(10):3293-9. PubMed ID: 1698178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between surface accessibility for PpmA, PsaA, and PspA and antibody-mediated immunity to systemic infection by Streptococcus pneumoniae.
    Gor DO; Ding X; Briles DE; Jacobs MR; Greenspan NS
    Infect Immun; 2005 Mar; 73(3):1304-12. PubMed ID: 15731027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective humoral response against pneumococcal infection in mice elicited by recombinant bacille Calmette-Guérin vaccines expressing pneumococcal surface protein A.
    Langermann S; Palaszynski SR; Burlein JE; Koenig S; Hanson MS; Briles DE; Stover CK
    J Exp Med; 1994 Dec; 180(6):2277-86. PubMed ID: 7964500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.